Make Home Page | Bookmark this page      
    
HOME
ABOUT US
SERVICES
BACK OFFICE
RESEARCH
ONLINE TRADING
Market
  
Market Analysis Company Information Corporate Actions Other Market
        Gainers & Losers         Advances & Declines         New Highs & Lows         Out / Under Performers
        Index Movers         Historical Returns         Sector Watch         Only Buyers and Sellers
        Value & Volume Toppers         Live Indices         Bulk Deals         Block Deals
        52 Week Highs & Lows         Exchange Holidays         Unusual Volume         Index Constituents
        Detailed Quotes         Company Snapshot         Board of Directors         Profit & Loss
        Quarterly Result         Balance Sheet         Key Financial Ratios         Monthly High Low
        Name Change         Company News         MF Holdings         Director's Report
        Peer Comparison         Company Background         Score Board         Share Holding Pattern
        Technical Chart         Interactive Chart
        BSE Announcements         NSE Announcements         Board Meetings         Book Closure
        Bonus Issues         Rights Issues         De-Listed Shares         Market Turnover
        Change Of Name         Split Of Face Value
        ADR Prices         Forex         FII Investment         MF Investment
        World Indices
Profit & Loss
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value
320.5640364
NSE Symbol
CIPLA
Div & Yield %
0.60
Market Cap (Rs. Cr.)
115033.60
P/E
34.98
EPS
40.73
Face Value
2
The purpose of the income statement is to show managers and investors whether the company made or lost money during the period being reported.
Home >> Equity >> Company Information >> Profit & Loss
 Mar 2023
Rs.Cr
Mar 2022
Rs.Cr
Mar 2021
Rs.Cr
Mar 2020
Rs.Cr
Mar 2019
Rs.Cr
Mar 2018
Rs.Cr
INCOME :      
Sales Turnover 15790.6015380.8211302.7112659.1512374.0111444.81
Excise Duty0.000.000.000.000.0054.91
Net Sales15790.6015380.8211302.7112659.1512374.0111389.90
Other Income 500.73742.05653.91892.85577.52334.88
Stock Adjustments -205.26541.93-6.4143.08-136.70212.05
Total Income16086.0716664.8011950.2113595.0812814.8311936.83
EXPENDITURE :      
Raw Materials 5496.166467.544097.204362.294371.464367.54
Power & Fuel Cost257.07247.58234.58253.95264.93239.01
Employee Cost 2380.682122.021703.581911.081839.841785.94
Other Manufacturing Expenses 988.99994.55906.09921.04861.96851.23
Selling & Administrative Expenses 2334.972107.171578.592093.922030.011786.12
Miscellaneous Expenses 520.79272.66-291.15452.66367.11454.08
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure11978.6612211.528228.899994.949735.319483.92
Operating Profit4107.414453.283721.323600.143079.522452.91
Interest 27.0226.9345.0736.0516.9711.90
Gross Profit4080.394426.353676.253564.093062.552441.01
Depreciation595.91546.62468.62599.78569.72529.61
Profit Before Tax3484.483879.733207.632964.312492.831911.40
Tax1011.10949.49756.27545.96576.43431.33
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-40.09-27.69-16.92100.1827.9911.55
Reported Net Profit2513.472957.932468.282318.171888.411468.52
Extraordinary Items -40.2848.8839.0991.4079.1511.89
Adjusted Net Profit2553.752909.052429.192226.771809.261456.63
Adjustment below Net Profit -10.5218.4813.71-49.53-32.59-26.56
P & L Balance brought forward17534.7714961.7112479.7210828.569214.317933.29
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 403.50403.350.00617.48241.57160.94
P & L Balance carried down19634.2217534.7714961.7112479.7210828.569214.31
Dividend0.000.000.00322.490.00241.54
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %425.00250.00250.00200.00150.00150.00
Dividend Per Share(Rs)8.505.005.004.003.003.00
Earnings Per Share-Unit Curr31.1436.6630.6128.7523.4418.24
Earnings Per Share(Adj)-Unit Curr31.1436.6630.6128.7523.4418.24
Book Value-Unit Curr305.25279.05247.10215.85195.88175.30
Book Value(Adj)-Unit Curr305.25279.05247.10215.85195.88175.30